Renaissance Technologies’s LAVA Therapeutics LVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,600
Closed -$18K 4118
2023
Q1
$18K Sell
10,600
-8,200
-44% -$13.9K ﹤0.01% 3839
2022
Q4
$66K Buy
+18,800
New +$66K ﹤0.01% 3737